Therefore, although GF5000 reduces ApoA-I protein expression in T2DM rats, we still believe that ApoA-I plays an important role in the regulation of glucolipid metabolism disorders in T2DM rats mediated by GF5000. Here, APOA1 is linked to type 2 diabetes mellitus.